30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

OrthoPediatrics Reports 1Q18 Revenue Growth +24% YoY -

OrthoPediatrics (KIDS) posted 1Q18 revenue of US $12.1MM, +23.9% vs. 1Q17.

  1Q18  1Q17  $ Change  % Change 
 Trauma $9.1  $7.7  $1.4  17.9% 
 Spine $2.7  $1.9  $0.8  39.7% 
 Arthroscopy/Soft Tissue Repair $0.3  $0.1  $0.2  186.0% 
Total  $12.1  $9.8  $2.3  23.9% 


While all three segments contributed to growth, leadership singled out strong U.S. scoliosis sales and strength in ex-U.S. regions, as well.

Within the quarter, KIDS increased investment in consigned sets to $5.5MM, and affirmed that they are on target to increase investments in set deployment to $10MM for the full year. Nine U.S. sales reps joined in 1Q, for a total of 84 reps focusing exclusively on the company. Overseas, KIDS added two new stocking distributors for a total of 37.

KIDS is launching five new surgical systems in 2018, starting with Titanium PediPlates and an upgrade to the PediFlex Advanced system. Others to come include an Osteogenesis Imperfecta Nail and PediFoot, which leadership claims will be the first pediatric fracture system for the foot.

After the quarter’s close, KIDS announced FDA 510(k) clearance for the Pediatric Nailing Platform | FEMUR, its 25th surgical system. This is the second lower extremity IM nail system that the company will launch this year.

Source: OrthoPediatrics Corp.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.